viewXpediator PLC

Xpediator makes Robert Ross permanent CEO

He has been working as the freight management services provider's joint interim CEO and chief financial officer

Xpediator PLC -

Xpediator PLC (LON:XPD) has appointed Robert Ross as chief executive officer of the group with immediate effect.

Ross has been working as joint interim CEO and chief financial officer of the freight management services provider.

The UK and Central and Eastern Europe-focused group said the board will shortly begin the search for a new permanent CFO.

Alex Borrelli, chairman of Xpediator, said: "Robert has shown since his arrival and in the last few months as joint interim CEO that he is a very able operator with the strategic and financial perspective to head the business. He is comfortable with leadership and has excellent knowledge and experience of the transport and logistics markets in which we operate.

"So after a thorough process involving both internal and external candidates, we are very pleased to be able to appoint Robert and we look forward to supporting him in the next phases of the company's development."

Quick facts: Xpediator PLC

Price: 38 GBX

Market: AIM
Market Cap: £53.82 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Xpediator PLC named herein, including the promotion by the Company of Xpediator PLC in any Content on the Site, the Company receives from said...


Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing...

FTSE 100 rallied in early trading on AstraZeneca’s COVID-19 vaccine trial and the easing of lockdown restrictions from December. London’s blue-chip index rose 20 to 6,371. AstraZeneca PLC (LON:AZN) announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University was...

on 23/11/20

2 min read